"[PSQ]'s patient fees are up 29% and this is during COVID, so that's impressive. Their longer term forecast is going from 109 centres to about 250... this is a buy" - David Novac

Francesco De Stradis from Ord Minnett and David Novac from Wealthwise Education go in-depth and stock specific. Stocks covered: CL1, JHC, PSQ, INR, SLC, BKW, WOR, OTW, EXP, CRW. Our stock of the day is Transurban (TCL).

Hosted on Acast. See acast.com/privacy for more information.